Inhibitory effects of efonidipine hydrochloride on contraction induced by several vasoconstrictors in porcine coronary artery: Comparison with effects of nifedipine and nisoldipine

Journal of Cardiovascular Pharmacology

Volumn 29, Issue 5, 1997, Pages 624-630

  Higashino, Raita ^a   Sato, Ryuichi ^a   Jin, Hiromasa ^a   Inoue, Naonori ^a   Fukuta, Yoshihisa ^a   Kurimoto, Tadashi ^a   Tamaki, Hajime ^a  

^a ZERIA PHARMACEUTICAL CO LTD   (Japan)

Author keywords

5 Hydroxytryptamine; Angina pectoris; Ca2+ channel blocker; Efonidipine hydrochloride; Endothelin 1; High K+; Porcine coronary artery; U46619

Indexed keywords

1,4 DIHYDROPYRIDINE DERIVATIVE; 15 HYDROXY 11ALPHA,9ALPHA EPOXYMETHANOPROSTA 5,13 DIENOIC ACID; 7 [3 [(4 PHENYLSEMICARBAZIDO)METHYL] 7 OXABICYCLO[2.2.1]HEPT 2 YL] 5 HEPTENOIC ACID; CALCIUM CHANNEL; CALCIUM ION; DALTROBAN; EFONIDIPINE; ENDOTHELIN 1; NIFEDIPINE; NISOLDIPINE; POTASSIUM CHLORIDE; SEROTONIN; THROMBOXANE A2 RECEPTOR BLOCKING AGENT; VASOCONSTRICTOR AGENT;

ANIMAL TISSUE; ARTICLE; CALCIUM TRANSPORT; CONTROLLED STUDY; CORONARY ARTERY CONSTRICTION; CORONARY ARTERY DILATATION; NONHUMAN; PRIORITY JOURNAL; SWINE;

15-HYDROXY-11 ALPHA,9 ALPHA-(EPOXYMETHANO)PROSTA-5,13-DIENOIC ACID; ANIMALS; BINDING, COMPETITIVE; CALCIUM CHANNEL BLOCKERS; CORONARY VESSELS; DIHYDROPYRIDINES; ENDOTHELIN-1; MUSCLE CONTRACTION; MUSCLE, SMOOTH, VASCULAR; NIFEDIPINE; NISOLDIPINE; NITROPHENOLS; ORGANOPHOSPHORUS COMPOUNDS; POTASSIUM; PROSTAGLANDIN ENDOPEROXIDES, SYNTHETIC; SEROTONIN; SWINE; THROMBOXANE A2; VASOCONSTRICTOR AGENTS;

EID: 0030925548     PISSN: 01602446     EISSN: None     Source Type: Journal    
DOI: 10.1097/00005344-199705000-00010     Document Type: Article

References (28)

1. McFadden EP, Clarke JG, Davies GJ, Kaski JC, Haider AW, Maseri A. Effect of intracoronary serotonin on coronary vessels in patients with stable angina and patients with variant angina. N Engl J Med 1991;324:648-54.
2. Shepherd JT, Vanhoutte PM. Spasm of the coronary arteries: causes and consequences (the scientist's viewpoint). Mayo Clin Proc 1985;60:33-46.
3. Toyo-oka T, Aizawa T, Suzuki N, et al. Increased plasma level of endothelin-1 and coronary spasm induction in patients with vasospastic angina pectoris. Circulation 1991;83:476-83.
4. Yasue H. Pathophysiology and treatment of coronary arterial spasm. Chest 1980;78:216-23.
5. Duncker DJ, Van Woerkens LJ, Serruys PW, Roelandt JR, Hugenholtz PG, Verdouw PD. Actions of nisoldipine in cardiovascular disease. Can J Cardiol 1989;5:266-74.
6. Kloner RA, Przyklenk K. Progress in cardioprotection: the role of calcium antagonists. Am J Cardiol 1990;66:2-9H.
7. Sakanashi M, Noguchi K, Kato T, Sunagawa R, Nagamine F, Nakasone J. Comparison of vasodilating effects of nisoldipine in anesthetized open-chest dogs. Arzneimittelforschung 1986;36: 1736-9.
8. Kanda M, Shirahase H, Kurahashi K, et al. Effects of the novel water-soluble calcium antagonist (+/-)-3-(4-allyl-1-piperazinyl)-2,2-dimethylpropyl methyl-1,4-dihydro-2,6-dimethyl-4-(3-nitrophenyl)-3,5-pyridinedicarboxylate dihydrochloride on the responses of isolated canine arteries. Arzneimittelforschung 1995;45:831-5.
9. Kasai H, Jinno Y, Kaneta S, et al. Comparison of the anti-vasoconstrictor effects of a novel vasodilator KRN2391, nicorandil and nifedipine on isolated porcine large coronary artery. Arch Int Pharmacodyn Ther 1993;321:63-71.
10. Liu JJ, Johnston CI, Buxton BF. Synergistic effect of nisoldipine and nitroglycerin on human internal mammary artery. J Pharmacol Exp Ther 1994;268:434-40.
11. Miwa A, Kasai H, Motoki K, et al. Effect of KRN2391, a novel vasodilator, on endothelin-1-induced contraction of porcine coronary artery: comparison with cromakalim, nitroglycerin and nifedipine. Arch Int Pharmacodyn Ther 1993;326:52-61.
12. Masuda Y, Iwama T, Yamashita T, et al. Vasorelaxing and receptor binding properties of NZ-105, a novel dihydropyridine derivative, in isolated rabbit aorta. Arch Int Pharmacodyn Ther 1991;312:86-103.
13. Tamura T, Saigusa A, Kokubun S. Mechanisms underlying the slow onset of action of a new dihydropyridine, NZ-105, on a cultured smooth muscle cell line. Naunyn Schmiedebergs Arch Pharmacol 1991;343:405-10.
14. Yamashita T, Masuda Y, Sakai T, Tanaka S, Kasuya Y. NZ-105, a new 1,4-dihydropyridine derivative: correlation between dihydropyridine receptor binding and inhibition of calcium uptake in rabbit aorta. Jpn J Pharmacol 1991;57:337-48.
15. 2+ and tension caused by KCl and norepinephrine in isolated rat aortas. J Cardiovasc Pharmacol 1995;25:262-7.
16. 3H]U46619 binding in pig aorta smooth muscle membranes. Eur J Pharmacol 1988;151:59-65.
17. Yamagishi T, Yanagisawa T, Taira N. Activation of phospholipase C by the agonist U46619 is inhibited by cromakalim-induced hyperpolarization in porcine coronary artery. Biochem Biophys Res Commun 1992;187:1517-22.
18. 2+ release in coronary artery. Cardiovasc Drugs Ther 1993;3:565-74.
19. Masuda Y, Takeguchi M, Arakawa C, et al. Antihypertensive and diuretic effects of NZ-105, a novel dihydropyridine derivative. Arch Int Pharmacodyn 1990;304:247-64.
20. Kazda S, Garthoff B, Meyer H, et al. Pharmacology of a new calcium antagonistic compound, isobutyl methyl 1,4-dihydro-2,6-dimethyl-4(2-nitrophenyl)-3,5-pyridinedicarboxylate (Nisoldipine, Bay K 5552). Arzneimittelforschung 1980;30:2144-62.
21. Godfraind T, Dessy C, Salomone S. A comparison of the potency of selective L-calcium channel blockers in human coronary and internal mammary arteries exposed to serotonin. J Pharmacol Exp Ther 1992;263:112-22.
22. + channel opener cromakalim in canine coronary artery. Jpn J Pharmacol 1992;59:291-9.
23. 2 in the rabbit coronary artery. Circ Res 1987;60:402-9.
24. 2 receptor. Circ Res 1988;62:494-505.
25. 2 receptor. Eur J Pharmacol 1991;206:15-21.
26. 2 receptor in the vasoconstrictor response of rat aorta to endothelin. J Pharmacol Exp Ther 1989;252:915-21.
27. 2. J Cardiovasc Pharmacol 1993;22:5328-31.
28. Kasuya Y, Ishikawa T, Yanagisawa M, Kimura S, Goto K, Masaki T. Mechanism of contraction to endothelin in isolated porcine coronary artery. Am J Physiol 1989;257:H1828-35.